Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX).

Full DD Report for CPIX

You must become a subscriber to view this report.


Recent News from (NASDAQ: CPIX)

Midday Gainers / Losers (08/24/2018)
Gainers:  GERN +28% . SSC +27% . CVM +18% . SPLK +16% . CPIX +16% . CRON +16% . CNAT +15% . REED +15% . ADSK +15% . BRY +14% . More news on: Geron Corporation, Seven Stars Cloud Group, Inc., Cel-Sci Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 24 2018 12:37
Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q2 2018 Results - Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2018 Earnings Conference Call August 14, 2018 4:30 pm ET Executives Erin Smith - IR A.J. Kazimi - CEO Martin E. Cearnal - EVP and Chief Commercial Officer Michael Bonner - Senior Director, Finance & Accounting and CFO Analysts ...
Source: SeekingAlpha
Date: August, 14 2018 22:11
Cumberland Pharmaceuticals beats by $0.09, beats on revenue
Cumberland Pharmaceuticals (NASDAQ: CPIX ): Q2 EPS of $0.01 beats by $0.09 . More news on: Cumberland Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 14 2018 16:16
Cumberland Pharmaceuticals Reports Second Quarter 2018 Financial Results
NASHVILLE, Tenn. , Aug. 14, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced second quarter 2018 financial results and Company updat...
Source: PR Newswire
Date: August, 14 2018 16:05
Cumberland Pharmaceuticals Appoints New Senior Executive
NASHVILLE, Tenn. , Aug. 13, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals (NASDAQ: CPIX) today announced the appointment of biopharmaceutical industry veteran Adam Haeberle , Ph.D. as senior director, clinical and regulatory affairs. His responsibilities will include overseeing ...
Source: PR Newswire
Date: August, 13 2018 10:00
Cumberland Pharmaceuticals To Announce Second Quarter 2018 Financial Results
NASHVILLE, Tenn. , Aug. 7, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2018 financial results after the market closes on Tuesday, August 14 , 2018.  A conference call and live Internet webcast will be held...
Source: PR Newswire
Date: August, 07 2018 16:05
Cumberland Pharmaceuticals' (CPIX) CEO A.J. Kazimi on Q1 2018 Results - Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2018 Results Conference Call May 08, 2018 04:30 PM ET Executives Erin Smith - Corporate Relations A. J. Kazimi - Founder, Chairman, CEO and President Marty Cearnal - Chief Commercial Officer, EVP and Director Michael Bonner - CFO and Se...
Source: SeekingAlpha
Date: May, 12 2018 01:06
Cumberland Pharmaceuticals misses by $0.07, misses on revenue
Cumberland Pharmaceuticals (NASDAQ: CPIX ): Q1 EPS of -$0.09 misses by $0.07 . More news on: Cumberland Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 08 2018 16:35
Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results
NASHVILLE, Tenn. , May 8, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced first quarter 2018 financial results. Net revenues for th...
Source: PR Newswire
Date: May, 08 2018 16:05
Cumberland Pharmaceuticals To Announce First Quarter 2018 Financial Results
NASHVILLE, Tenn. , May 1, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2018 financial results after the market closes on Tuesday, May 8 , 2018.  A conference call and live Internet webcast will be held on T...
Source: PR Newswire
Date: May, 01 2018 09:35

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-176.006.026.41265.7451,811
2018-12-145.745.765.92575.743,161
2018-12-136.005.996.005.802,395
2018-12-126.03416.03416.03416.0341234
2018-12-116.256.2656.286.183,480

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-174,6008,12456.6224Short
2018-12-1481,7460.4582Cover
2018-12-138001,37758.0973Short
2018-12-1155692360.2384Short
2018-12-104001,19633.4448Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CPIX.


About Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)

Logo for Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $92,661,948 - 05/15/2018
  • Issue and Outstanding: 15,652,356 - 03/06/2018

 


Recent Filings from (NASDAQ: CPIX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 15 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 09 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 09 2018

 

 


Daily Technical Chart for (NASDAQ: CPIX)

Daily Technical Chart for (NASDAQ: CPIX)


Stay tuned for daily updates and more on (NASDAQ: CPIX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CPIX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CPIX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CPIX and does not buy, sell, or trade any shares of CPIX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/